Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bojing Wang"'
Autor:
Bojing Wang, Brittany S. White, William Ferguson, Alberto Coustasse, Chris Miller, Jessica McNair
Publikováno v:
International Journal of Healthcare Management. 14:1457-1462
Consumer-driven health plans (CDHPs) have been identified as a high-deductible insurance option increasing consumer responsibility while decreasing healthcare expenditures. There has been an increa...
Autor:
Debra G. Goodwin, Tarek S. Mansour, Kenneth C. Appell, Katherine J. Seidl, Amha G. Hewet, Maria L. Webb, Min Gao, James D. Clark, Steve Tam, Martin Hegen, Elizabeth Quadros, Peter T. Symanowicz, Jenny Togias, Jennifer Lussier, Scott H. Schelling, Michael Ohlmeyer, Bojing Wang, Xin Xu, Earl F. Kimble, Mary Collins, Jorge Quintero, Rustem Krykbaev, Dejun Xuan, Cheryl Nickerson-Nutter, Richard Harrison, Yuefei Shao, Christopher Wrocklage, Tsung H. Lin, Andrew G. Cole
Publikováno v:
Arthritis & Rheumatism. 62:2283-2293
Objective All γ-chain cytokines signal through JAK-3 and JAK-1 acting in tandem. We undertook this study to determine whether the JAK-3 selective inhibitor WYE-151650 would be sufficient to disrupt cytokine signaling and to ameliorate autoimmune dis
Autor:
Anthony M. Fletcher, John C. Kozlosky, Courtni Newsome, Jean G Sathish, Frank J. Simutis, Michael J. Graziano, Annette Capozzi, Daniel Szatkowski, Karen Price, John J. Engelhardt, Lila Ramaiah, Austin Thekkumthala, Helen G. Haggerty, Jennifer Wheeler, James Crona, Bojing Wang, Wendy J. Freebern, Rima Srour, Todd Bunch
Publikováno v:
Molecular Cancer Therapeutics. 17:LB-B33
Ipilimumab is a fully human immunoglobulin G1 (IgG1) monoclonal antibody against cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), an inhibitory receptor expressed on activated effector T cells and regulatory T cells (Treg), that inhibits the bin
Autor:
Celia Kingsbury, Irina Neagu, Ming You, Haengsoon Park, Tsung H. Lin, Koc-Kan Ho, Elizabeth Quadros, Maria L. Webb, Michael Ohlmeyer, Yuefei Shao, Matthew Sills, Jeffrey J. Letourneau, Andrew G. Cole, Yingchun Lu, Earl F. Kimble, Jorge Quintero, Riviello Christopher, Ray Anthony James, Bojing Wang, Vidyadhar M. Paradkar, Adolph Bohnstedt, Kenneth C. Appell, David J. Diller
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 19:6788-6792
A novel class of Janus tyrosine kinase 3 (JAK3) inhibitors based on a 2-benzimidazoylpurinone core structure is described. Through substitution of the benzimidazoyl moiety and optimization of the N-9 substituent of the purinone, compound 24 was ident
Publikováno v:
Endocrinology. 141:4583-4591
Insulin-like growth factor I (IGF-I) is a potent mitogen for both normal and transformed mammary epithelial cells (MEC), and IGF-binding protein-3 (IGFBP-3) potentiates IGF-I action in these cells. The synthesis of IGFBP-3 is stimulated by both IGF-I
Autor:
Katherine J. Seidl, Tsung H. Lin, Martin Hegen, Elizabeth Quadros, Cheryl L. Nickerson-Nutter, Kenneth C. Appell, Andrew G. Cole, Yuefei Shao, Steve Tam, Michael Ohlmeyer, Bojing Wang, Debra G. Goodwin, Earl F. Kimble, Jorge Quintero, Min Gao, Peter Symanowicz, Christopher Wrocklage, Jennifer Lussier, Scott H. Schelling, Amha G. Hewet, Dejun Xuan, Rustem Krykbaev, Jennifer Togias, Richard Harrison, Xin Xu, Mary Collins, James D. Clark, Maria L. Webb
Publikováno v:
Cytokine. 48:78
Autor:
Lin, Tsung H., Hegen, Martin, Quadros, Elizabeth, Nickerson-Nutter, Cheryl L., Appell, Kenneth C., Cole, Andrew G., Yuefei Shao, Tam, Steve, Ohlmeyer, Michael, Bojing Wang, Goodwin, Debra G., Kimble, Earl F., Quintero, Jorge, Min Gao, Symanowicz, Peter, Wrocklage, Christopher, Lussier, Jennifer, Schelling, Scott H., Hewet, Amha G., Dejun Xuan
Publikováno v:
Arthritis & Rheumatism; Aug2010, Vol. 62 Issue 8, p2283-2293, 11p
Autor:
Yamei W; Department of Hematology, The First Affiliated Hospital, Chinese PLA General Hospital, Beijing 100048, China., Rongmu L; Department of Hematology, Affiliated BaYi Children's Hospital, PLA Army General Hospital, Beijing 100700, China., Yongbin C; Department of Hematology, The First Affiliated Hospital, Chinese PLA General Hospital, Beijing 100048, China., Yingjian S; Department of Hematology, Affiliated BaYi Children's Hospital, PLA Army General Hospital, Beijing 100700, China., Xiaohong L; Department of Hematology, The First Affiliated Hospital, Chinese PLA General Hospital, Beijing 100048, China., Xiaomei Z; Department of Hematology, Affiliated BaYi Children's Hospital, PLA Army General Hospital, Beijing 100700, China., Pei Y; Department of Hematology, The First Affiliated Hospital, Chinese PLA General Hospital, Beijing 100048, China., Zhenlan D; Department of Hematology, Affiliated BaYi Children's Hospital, PLA Army General Hospital, Beijing 100700, China., Haitao W; Department of Hematology, The First Affiliated Hospital, Chinese PLA General Hospital, Beijing 100048, China., Jing W; Department of Hematology, The First Affiliated Hospital, Chinese PLA General Hospital, Beijing 100048, China., Bojing W; Department of Hematology, The First Affiliated Hospital, Chinese PLA General Hospital, Beijing 100048, China., Xiaoxiong W; Department of Hematology, The First Affiliated Hospital, Chinese PLA General Hospital, Beijing 100048, China., Wanming D; Department of Hematology, The First Affiliated Hospital, Chinese PLA General Hospital, Beijing 100048, China.; Department of Hematology, Affiliated BaYi Children's Hospital, PLA Army General Hospital, Beijing 100700, China.; Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China.
Publikováno v:
Oncotarget [Oncotarget] 2017 Jul 31; Vol. 8 (48), pp. 83817-83830. Date of Electronic Publication: 2017 Jul 31 (Print Publication: 2017).